Emergent BioSolutions (EBS) Tax Provisions (2011 - 2026)

Emergent BioSolutions' Tax Provisions history runs 16 years deep, the most recent figure standing at $6.6 million for Q1 2026.

• In Q1 2026, Tax Provisions fell 73.28% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $12.1 million (down 82.54% YoY), while the FY2025 annual figure was $30.2 million, down 36.69% from the prior year.
• Tax Provisions was $6.6 million for Q1 2026 at Emergent BioSolutions, up from $3.9 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $27.6 million in Q3 2024 to a low of -$26.4 million in Q2 2022.
• Historically, Tax Provisions has averaged $6.6 million across 5 years, with a median of $5.6 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Tax Provisions slumped 1115.38% in 2022, then jumped 25700.0% in 2023.
• A 5-year view of Tax Provisions shows it stood at $5.6 million in 2022, then sank by 189.29% to -$5.0 million in 2023, then jumped by 174.0% to $3.7 million in 2024, then gained by 5.41% to $3.9 million in 2025, then surged by 69.23% to $6.6 million in 2026.
• The last three Tax Provisions figures came in at $6.6 million (Q1 2026), $3.9 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.